Infectious Diseases 1110 - Infectious Disease Alert - Oct 01, 2007

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Editor
Frank Bia, MD, MPH
Professor of Medicine and Laboratory Medicine
Yale University School of Medicine

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editors, HIV

Associate Editors
Dean L. Winslow, MD, FACP
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor of Medicine
Stanford University School of Medicine
Section Editor, HIV

Jessica C. Song, MA, Pharm D
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Pharmacy Residency Coordinator
Santa Clara Valley Medical Center
Section Editor, Managed Care

Philip Fischer, MD, DTM&H Professor of Pediatrics
Division of Pediatric and Adolescent Medicine
Mayo Clinic, Rochester, MN.

Lin Chen, MD
Assistant Clinical Professor
Harvard Medical School
Director Travel Resource Center
Mount Auburn Hospital
Cambridge, MA

Author
Paul Hsiao

Subjects:

  • Virulent Klebsiella Pneumoniae
  • Atazanavir-Associated Kidney Stones
  • A Review of the Effects of Antiretroviral Agents on Lipid Panels of HIV-Positive Patients
  • Say No to Norovirus
  • Malaria and Travelers
  • Updates

Objectives:

  • To discuss the diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy.

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Editor, Frank Bia, MD, MPH received funds from Johnson & Johnson.

Peer Reviewer, Connie Price, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Updates Author, Carol A. Kemper, MD, FACP, reports no financial relationships relevant to this field of study.

Associate Editors Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant to Siemens Diagnostics and is on the Speakers Bureaus of Boehringer-Ingelheim and GSK.

Jessica C. Song, MA, Pharm D, Philip Fischer, MD, DTM&H, and Lin Chen, MD report no financial relationships relevant to this field of study

Author Paul Hsiao, report no financial relationships relevant to this field of study

Copyright 2007 AHC Media. All rights reserved.